Meckler Jeffrey A (CIK 0001506916)

Latest company ownership

Shares held
657,161
Last filed at
Mar 17, 2016
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q4 2025Q4
Shares held
19,500
Last filed at
May 16, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q4 2025Q4
Shares held
12,136
Last filed at
Jul 29, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 30, 2024 Sep 30, 2024 Travere Therapeutics, Inc. Director Sell 7.5 -40,000 -33.06% ✓ $562.3K
Nov 18, 2022 Nov 22, 2022 Indaptus Therapeutics, Inc. CEO Buy 91.3 +10,000 15.30% ✗ $18.9K
Sep 8, 2022 Sep 12, 2022 Indaptus Therapeutics, Inc. CEO Buy 91.3 +10,308 18.72% ✗ $28.9K
Sep 6, 2022 Sep 8, 2022 Indaptus Therapeutics, Inc. CEO Buy 91.3 +9,692 21.36% ✗ $24.8K
Jun 6, 2022 Jun 7, 2022 Indaptus Therapeutics, Inc. CEO Buy 95.0 +19,727 76.92% ✗ $51.9K
Nov 18, 2021 Nov 19, 2021 Indaptus Therapeutics, Inc. CEO Buy 95.0 +11,187 77.37% ✗ $65.1K
Sep 14, 2021 Sep 16, 2021 Indaptus Therapeutics, Inc. CEO Buy 95.0 +12,000 487.80% ✗ $84K
Mar 15, 2016 Mar 17, 2016 Cocrystal Pharma, Inc. CEO Buy 95.0 +294,118 81.01% ✗ $150K
Mar 4, 2016 Mar 7, 2016 Travere Therapeutics, Inc. Director Buy 95.0 +5,000 10.64% ✗ $76.6K
Mar 3, 2016 Mar 3, 2016 Travere Therapeutics, Inc. Director Buy 95.0 +10,000 27.03% ✗ $144.5K
Dec 23, 2015 Dec 28, 2015 Cocrystal Pharma, Inc. CEO Buy 95.0 +100,000 38.02% ✗ $57.9K
Mar 25, 2015 Mar 27, 2015 Cocrystal Pharma, Inc. Director Buy 95.0 +163,043 163.04% ✗ $150K
Dec 11, 2014 Dec 15, 2014 Cocrystal Pharma, Inc. Director Buy 91.3 +100,000 100.00% ✗ $45.6K
Nov 25, 2014 Nov 25, 2014 Travere Therapeutics, Inc. Director Buy 95.0 +15,000 75.00% ✗ $129K